Advertisement
Screener

Fusion Pharmaceuticals Inc. Form 10-Q: Quarterly report

Fusion Pharmaceuticals Inc. Form 10-Q: Quarterly report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-05-07: Form 10-Q; Period of report 2024-03-31; Description 10-Q; Document fusn-20240331.htm.
  • 2023-11-07: Form 10-Q; Period of report 2023-09-30; Description 10-Q; Document fusn-20230930.htm.
  • 2023-08-08: Form 10-Q; Period of report 2023-06-30; Description 10-Q; Document fusn-20230630.htm.
  • 2023-05-11: Form 10-Q; Period of report 2023-03-31; Description 10-Q; Document fusn-20230331.htm.
FiledFormPeriod of reportDescriptionDocument
2024-05-0710-Q2024-03-3110-Qfusn-20240331.htm
2023-11-0710-Q2023-09-3010-Qfusn-20230930.htm
2023-08-0810-Q2023-06-3010-Qfusn-20230630.htm
2023-05-1110-Q2023-03-3110-Qfusn-20230331.htm
2022-11-0810-Q2022-09-3010-Qfusn-20220930.htm
2022-08-0910-Q2022-06-3010-Qfusn-10q_20220630.htm
2022-05-1010-Q2022-03-3110-Qfusn-10q_20220331.htm
2021-11-0910-Q2021-09-3010-Qfusn-10q_20210930.htm
2021-08-1010-Q2021-06-3010-Qfusn-10q_20210630.htm
2021-05-1110-Q2021-03-3110-Qfusn-10q_20210331.htm
2020-11-1010-Q2020-09-3010-Qfusn-10q_20200930.htm
2020-08-1110-Q2020-06-3010-Qfusn-10q_20200630.htm